Chapter 2

Characteristics of Admissions by Primary Substance: 2011

All Admissions Aged 12 and Older
Alcohol Only
Alcohol with Secondary Drug Abuse
Heroin
Opiates Other than Heroin
Smoked Cocaine (Crack)
Non-Smoked Cocaine
Marijuana/Hashish
Methamphetamine/Amphetamines
Tranquilizers
Sedatives
Hallucinogens
Phencyclidine (PCP)
Inhalants


This chapter highlights important findings in the 2011 TEDS data. The tables include items in the TEDS Minimum and Supplemental Data Sets for 2011. (See Appendix B for a complete data dictionary.) Data are tabulated as percentage distributions of treatment admissions according to primary substance of abuse. It is important to note that percentages in charts, narrative lists, and percentage distributions in tables may not add to 100 percent due to rounding.

The Minimum Data Set consists of 19 items that include:

The Supplemental Data Set consists of 17 items that include psychiatric, social, and economic measures.

Not all States report all data items in the Minimum and Supplemental Data Sets. Most States report the Minimum Data Set for all or nearly all TEDS admissions. However, the items reported from the Supplemental Data Set vary greatly across States.

The figures in this chapter represent counts of admissions for each primary substance of abuse by gender, age, and race/ethni­city (non-Hispanic White, non-Hispanic Black, Hispanic of Mexican origin, Hispanic of Puerto Rican origin,1 American Indian/Alaska Native, and Asian/Pacific Islander).


1 Hispanics of Mexican and Puerto Rican origin made up 62 percent of all admissions of Hispanic origin in 2011.

All Admissions Aged 12 and Older


2 Percentages do not sum to total due to rounding.

Figure 5. All admissions, by gender, age, and race/ethnicity: 2011

Figure 5.Line chart comparing All admissions, by gender, age, and race/ethnicity: 2010

Alcohol Only

Figure 6. Alcohol-only admissions, by gender, age, and race/ethnicity: 2011

Figure 6. Line chart comparing Alcohol-only admissions, by gender, age, and race/ethnicity: 2010

Alcohol with Secondary Drug Abuse

Figure 7. Alcohol admissions with secondary drug abuse, by gender, age, and race/ethnicity: 2011

Figure 7. Line chart comparing Alcohol admissions with secondary drug abuse, by gender, age, and race/ethnicity: 2010

Heroin

Figure 8. Heroin admissions, by gender, age, and race/ethnicity: 2011

Figure 8. Line chart comparing Heroin admissions, by gender, age, and race/ethnicity: 2010

Opiates Other than Heroin

Figure 9. Non-heroin opiate admissions, by gender, age, and race/ethnicity: 2011

Figure 9. Line chart comparing Non-heroin opiate admissions, by gender, age, and race/ethnicity: 2010

Smoked Cocaine (Crack)

Figure 10. Smoked cocaine (crack) admissions, by gender, age, and race/ethnicity: 2011

Figure 10. Line chart comparing Smoked cocaine (crack) admissions, by gender, age, and race/ethnicity: 2010

Non-Smoked Cocaine

Figure 11. Non-smoked cocaine admissions, by gender, age, and race/ethnicity: 2011

Figure 11. Line chart comaparing Non-smoked cocaine admissions, by gender, age, and race/ethnicity: 2010

Marijuana/Hashish

Figure 12. Marijuana/hashish admissions, by gender, age, and race/ethnicity: 2011

Figure 12. Line chart comparing Marijuana/hashish admissions, by gender, age, and race/ethnicity: 2010

Methamphetamine/Amphetamines

Figure 13. Methamphetamine/amphetamine admissions, by gender, age, and race/ethnicity: 2011

Figure 13. Line chart comparing Methamphetamine/amphetamine admissions, by gender, age, and race/ethnicity: 2010

Tranquilizers

Figure 14. Tranquilizer admissions, by gender, age, and race/ethnicity: 2011

Figure 14. Line chart comparing Tranquilizer admissions, by gender, age, and race/ethnicity: 2010

Sedatives

Figure 15. Sedative admissions, by gender, age, and race/ethnicity: 2011

Figure 15. Line chart comparing Sedative admissions, by gender, age, and race/ethnicity: 2010

Hallucinogens

Figure 16. Hallucinogen admissions, by gender, age, and race/ethnicity: 2011

Figure 16. Line chart comparing Hallucinogen admissions, by gender, age, and race/ethnicity: 2010

Phencyclidine (PCP)

Figure 17. Phencyclidine (PCP) admissions, by gender, age, and race/ethnicity: 2011

Figure 17. Line chart comparing Phencyclidine (PCP) admissions, by gender, age, and race/ethnicity: 2010

Inhalants

Figure 18. Inhalant admissions, by gender, age, and race/ethnicity: 2011

Figure 18. Line chart comparing Inhalant admissions, by gender, age, and race/ethnicity: 2010

TO TABLES

To table of contents

To Table of Contents